← Open Payments lookup

KRISTI ORBAUGH: Open Payments

NPI 1134191679 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$250,975 in 419 payments from 13 companies in 2025. Trend: 2023 $290,584 · 2024 $250,419 · 2025 $250,975

Speaker / faculty: $150,223Travel & lodging: $74,866Consulting: $14,926Food & beverage: $6,538Speaker / faculty: $4,423
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP125$74,279
Daiichi Sankyo Inc.110$71,961
Stemline Therapeutics Inc.42$22,760
Lilly USA, LLC39$21,042
Gilead Sciences, Inc.38$17,265
PFIZER INC.16$15,708
SOBI, INC15$9,584
Boehringer Ingelheim Pharmaceuticals, Inc.15$8,810
Exelixis Inc.8$6,030
E.R. Squibb & Sons, L.L.C.7$2,115

Products named: Enhertu, DATROWAY, Orserdu, Trodelvy, IBRANCE, VERZENIO, Vonjo, IMFINZI.

Industry payments across IN — which companies pay providers there.